Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Conference News ESC 2025

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

Caitlin E. Cox

September 01, 2025

News Daily News

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

L.A. McKeown

May 16, 2025

News Daily News

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

L.A. McKeown

March 06, 2025

News Daily News

High-Sensitivity Troponins May Overestimate PE Severity

L.A. McKeown

November 28, 2023

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

L.A. McKeown

August 30, 2022

News Daily News

VTE Risk Higher With COVID-19 Than With Flu

Todd Neale

August 18, 2022

News Daily News

Select COVID-19 Patients May Benefit From Postdischarge Anticoagulation

Todd Neale

November 25, 2021

News Daily News

Uptick in Heparin-Induced Thrombocytopenia in COVID-19 Complicates Care

Michael O'Riordan

October 02, 2020

News Daily News

COVID-19 Patients With Arterial Leg Thromboses Risk Amputation and Death

L.A. McKeown

July 23, 2020

News Daily News

In COVID-19 Pulmonary Embolism, Nontraditional Risk Factors Dominate

Yael L. Maxwell

July 21, 2020

News Daily News

Meta-analysis: Vena Cava Filters Safe, Effective in Reducing Pulmonary Embolism

March 05, 2014

News Daily News

Endovascular Therapy for DVT Appears Safe, Effective in Registries

January 22, 2013

News Daily News

Single-Center Studies Build Case for Venous Angioplasty in Multiple Sclerosis

Caitlin E. Cox

April 05, 2012

Advertisement

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

High-Sensitivity Troponins May Overestimate PE Severity

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

VTE Risk Higher With COVID-19 Than With Flu

Select COVID-19 Patients May Benefit From Postdischarge Anticoagulation

Uptick in Heparin-Induced Thrombocytopenia in COVID-19 Complicates Care

COVID-19 Patients With Arterial Leg Thromboses Risk Amputation and Death

In COVID-19 Pulmonary Embolism, Nontraditional Risk Factors Dominate

Meta-analysis: Vena Cava Filters Safe, Effective in Reducing Pulmonary Embolism

Endovascular Therapy for DVT Appears Safe, Effective in Registries

Single-Center Studies Build Case for Venous Angioplasty in Multiple Sclerosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content